Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Pseudacidovorax

ABSTRACT: Pseudacidovorax sp. overview

PROVIDER: PRJNA1117112 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR5194645_1.fastq.gz	Fastqsanger.gz
	SRR5194645_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 3 of 3

Similar Datasets

Pseudacidovorax intermedius

Project description:Pseudacidovorax intermedius overview

| PRJNA186711 | ENA

Pseudacidovorax sp. RU35E

Project description:Pseudacidovorax sp. RU35E Genome sequencing

| PRJNA345689 | ENA

Pseudacidovorax intermedius strain:NS331

Project description:Pseudacidovorax intermedius Genome Sequencing

| PRJNA278222 | ENA

Pseudacidovorax sp. 1753 isolate:DPS 1753

Project description:Pseudacidovorax sp. 1753 isolate:DPS 1753 Genome sequencing

| PRJNA1115522 | ENA

Pseudacidovorax intermedius strain:DSM 21352

Project description:Pseudacidovorax intermedius DSM 21352 genome sequencing

| PRJNA463368 | ENA

Pseudacidovorax intermedius NH-1

Project description:Pseudacidovorax intermedius NH-1 Genome sequencing and assembly

| PRJNA179323 | ENA

Project description:Pseudacidovorax sp. RU35E

| PRJEB18867 | ENA

Pseudacidovorax intermedius strain:SORGH_AS 961

Project description:Chryseobacterium sp. SORGH_AS 961 genome sequencing

| PRJNA957365 | ENA

Transcriptomic and epigenetic dissection of spinal ependymomas (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutation [RNA-seq]

Project description:Background: Ependymomas encompass multiple, clinically relevant tumor types based on localization and molecular profiles. Although tumors of the methylation class “spinal ependymoma” (SP-EPN) represent the most common intramedullary neoplasms in children and adults, their developmental origin is ill-defined, molecular data are scarce, and the potential heterogeneity within SP-EPN remains unexplored. The only known recurrent genetic events in SP-EPN are loss of chromosome 22q and NF2 mutations, but neither types and frequency of these alterations nor their clinical meaning have been described in a large, epigenetically defined series. Methods: We mapped SP-EPN transcriptomes (n=76) to developmental atlases of the developing and adult spinal cord to uncover potential developmental origins of these tumors. In addition, transcriptomic, epigenetic (n=234), genetic (n=140), and clinical analyses (n=115) were integrated for a detailed overview on this entity. Results: Integration of transcriptomic ependymoma data with single-cell atlases of the spinal cord identified mature adult ependymal cells to display highest similarities to SP-EPN. Unsupervised hierarchical clustering of tumor data together with integrated analysis of methylation profiles identified two molecular SP-EPN subtypes. Subtype 1 predominantly contained NF2 wild type sequences with regular NF2 expression but revealed more extensive copy number alterations. Subtype 2 harbored previously known germline or sporadic NF2 mutations and was NF2-deficient in most cases, more often showed multilocular disease, and demonstrated a significantly reduced progression-free survival. Conclusion: Based on integrated molecular profiling of a large tumor series we identify two distinct SP-EPN subtypes with important implications for genetic counseling, patient surveillance, and drug development priorities.

2024-01-26 | GSE242992 | GEO